Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

OS

  • You have access
    Prognostic Value of Immune Cells Subsets Within the Tumor Microenvironment in Patients With Rectal Adenocarcinoma
    TAO-WEI KE, SENAMILE TEMHLANGA ZWANE, SHU-FEN CHIANG, TSUNG-WEI CHEN, PEI-CHEN YANG, LIANG-CHI CHEN, YUN-SHAN LIN, WILLIAM TZU-LIANG CHEN, K.S. CLIFFORD CHAO and KEVIN CHIH-YANG HUANG
    Anticancer Research February 2024, 44 (2) 787-796; DOI: https://doi.org/10.21873/anticanres.16870
  • You have access
    Comparison of Minimally Invasive Surgery and Abdominal Surgery Among Patients With Cervical Cancer
    DOMINIK RATIU, CHRISTIAN LUNCESCU, BERND MORGENSTERN, CHRISTIAN EICHLER, BERTHOLD GRÜTTNER, SEBASTIAN LUDWIG, PETER MALLMANN and FABINSHY THANGARAJAH
    Anticancer Research May 2019, 39 (5) 2661-2664; DOI: https://doi.org/10.21873/anticanres.13390
  • You have access
    Predictive and Prognostic Significance of Sodium Levels in Patients with NSCLC Treated by Erlotinib
    MARTIN SVATON, ONDREJ FIALA, MILOS PESEK, FRANTISEK BRUHA, PETR MUKENSNABL, JAROSLAV RACEK, MAREK MINARIK and ZDENEK BORTLICEK
    Anticancer Research December 2014, 34 (12) 7461-7465;
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire